Frontlight ResearchEarly access
Trial site
Samodzielny Publiczny Specjalistyczny Szpital Zachodni Im.Sw.Jana Pawla II
- 9running trials
- 11closed trials
The trials here
What the 20 trials at this site are about, from their registry records.
- Conditions
- Heart failure7 trials
- Stroke7 trials
- Atrial fibrillation4 trials
- Coronary artery disease3 trials
- Deep vein thrombosis and pulmonary embolism2 trials
- High blood pressure2 trials
- Obesity2 trials
- Chronic kidney disease1 trial
- Multiple sclerosis1 trial
- Nephrotic syndrome1 trial
- Pulmonary arterial hypertension1 trial
- Phase
- Phase 313 trials
- Phase 27 trials
- Status
- Completed10 trials
- Recruiting5 trials
- Active, not recruiting2 trials
- Not yet recruiting2 trials
- Terminated1 trial
- Lead sponsor
- Novo Nordisk A/S4 trials
- Bayer3 trials
- Regeneron Pharmaceuticals2 trials
- Ribocure Pharmaceuticals AB2 trials
- Amgen1 trial
- and 8 more
Running trials
Not yet recruiting
Recruiting
Recruiting
Recruiting
A Study to Test How Well BAY 3670549 Works and How Safe it is in Patients With Atrial Fibrillation
Recruiting
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
Recruiting
Active, not recruiting
LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF
Active, not recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Atrial fibrillation2 recruiting
- Obesity2 recruiting
- Coronary artery disease1 recruiting
- Deep vein thrombosis and pulmonary embolism1 recruiting
- Heart failure1 recruiting
- High blood pressure1 recruiting
- Nephrotic syndrome1 recruiting
- Stroke1 recruiting
Closed trials
Recruiting
Completed
Completed
Completed
Active, not recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Site data: EU CTIS (euclinicaltrials.eu)Updated 19 Nov 2026